# Immiseal™ Dural Sealant Post-Market Registry Study

> **NCT07651826** · — · RECRUITING · sponsor: **Medprin Regenerative Medical Technologies Co., Ltd.** · enrollment: 85 (estimated)

## Conditions studied

- Dural Defect
- Cerebrospinal Fluid Leak
- Neurosurgical Procedures

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07651826
- **Lead sponsor:** Medprin Regenerative Medical Technologies Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-17
- **Primary completion:** 2026-08-15
- **Final completion:** 2026-11-23
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07651826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07651826, "Immiseal™ Dural Sealant Post-Market Registry Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07651826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*